Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
38,62 USD | -0,97% | -6,44% | +326,74% |
Attività
Numero di dipendenti: 253
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody Oligonucleotide Conjugates
100,0
%
| 9 | 100,0 % | 10 | 100,0 % | +3,64% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 10 | 100,0 % | +3,64% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 13/11/12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 01/10/19 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 19/05/20 |
Steven G. Hughes
CTO | Chief Tech/Sci/R&D Officer | 57 | 23/02/22 |
W. Flanagan
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/01/21 |
Arthur Levin
BRD | Director/Board Member | 70 | 01/10/13 |
Teresa McCarthy
HRO | Human Resources Officer | 60 | 01/08/20 |
Corporate Officer/Principal | - | 01/04/21 | |
Corporate Officer/Principal | 46 | 25/08/21 | |
John W. Wallen
LAW | General Counsel | 66 | 13/11/12 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 01/10/13 |
Carsten Boess
BRD | Director/Board Member | 57 | 13/04/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 22/08/19 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 01/10/19 |
Jean Kim
BRD | Director/Board Member | 50 | 11/01/21 |
Troy Wilson
FOU | Founder | 55 | 13/11/12 |
Simona Skerjanec
BRD | Director/Board Member | 59 | 14/05 |
Corporate Officer/Principal | 46 | 25/08/21 | |
Noreen Henig
BRD | Director/Board Member | 59 | 22/08/19 |
Tamar Thompson
BRD | Director/Board Member | 50 | 11/01/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 106 144 486 | 100 681 004 ( 94,85 %) | 0 | 94,85 % |
Coordinate società
Avidity Biosciences, Inc.
10578 Science Center Drive Suite 125
92121, San Diego
+
http://www.aviditybiosciences.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+326,74% | 4,14 Mrd | |
+4,14% | 97,7 Mrd | |
+4,21% | 41,43 Mrd | |
-11,86% | 32,85 Mrd | |
+80,99% | 29,33 Mrd | |
-14,25% | 15,47 Mrd | |
-7,36% | 12,89 Mrd | |
-13,08% | 11,51 Mrd | |
+176,65% | 10,74 Mrd | |
-57,36% | 8,97 Mrd |
- Borsa valori
- Azioni
- Azione RNA
- Società Avidity Biosciences, Inc.